UK-developed leukaemia cell therapy to be offered on NHS
Developed by UCL spinout Autolus, Aucatzyl will be launched imminently across England and Wales.
Cytiva Navigating cell therapy WP 4
Aspen closes $115m in Series C to advance Parkinson’s cell therapy
USPTO grants patent to Genprex’s Reqorsa gene therapy
FDA approves Sarepta’s updated Elevidys label for DMD
FDA unveils new pathway to usher bespoke therapies to market
Lyell acquires worldwide rights from ICT to CAR T-cell therapy
Eli Lilly keeps up ophthalmic gene therapy push with $475m MeiraGTx deal
FDA halts uniQure’s plans for Huntington’s disease gene therapy
